Zainab Syed

Ms. Zainab Syed


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in Dairy
Verified
Journal Article
Open access
PDF file
MAMuhammad Abubakar
Muhammad Abubakar
ZSZainab Syed
Zainab Syed
SMShumaila Manzoor
Shumaila Manzoor
MAMuhammad Javed Arshad
Muhammad Javed Arshad
Milk is seen as a chief source of protein and other biologically available nutrients for human beings. Pakistan, the fourth largest milk-producing country, is badly affected by the contagious transboundary apthoviral disease of ungulate animals; the foot and mouth disease (FMD) virus. FMD is endemic in Pakistan and has caused significant economic loss to the dairy industry in the form of a profound decrease in milk production and increased morbidity and deaths of dairy animals. Inclusively, the case fatality ratio of FMD was 15.11%. Of the seven FMDV serotypes, (O, A, C, Asia 1, SAT 1, SAT 2, and SAT 3), three serotypes (O, A, and Asia-1) are endemic in Pakistan. Rapid and highly sensitive diagnostic tools are required for efficient control of this disease. Presently, FMD in the laboratory is diagnosed via ELISA and molecular approaches, i.e., RT-PCR. Serotype-specific RT-PCR analysis not only confirms ELISA serotyping results but can also be used for the screening of ELISA negative samples. Genotypically, FMDV serotype O has a topotype (Middle East–South Asia (ME–SA) and lineage PanAsia-2) that is reported frequently from different areas of Pakistan. Confirmed cases of serotype A and Asia-1 are also reported. The information gathered can be used for understanding the molecular epidemiology of FMD in Pakistan. Further studies on the molecular dynamics of FMD could be useful for ensuring the timely diagnosis of this deadly pathogen, which would ultimately be beneficial for the mass vaccination programs of FMD in Pakistan.

7 July 2026
Verified
Book Chapter
Open access
PDF file
ZSZainab Syed
Zainab Syed
NANoor ul Ain
Noor ul Ain
The vitamin B complex represents a distinct group of water-soluble micronutrients, including thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folic acid (B9), and cobalamin (B12), that function as essential coenzymes in numerous catabolic and anabolic reactions. These vitamins are central to carbohydrate, lipid, and protein metabolism and play a crucial part in neurotransmitter synthesis, energy production, carbon uptake, and overall neurological processes. Through interconnected molecular pathways, the B complex acts as cofactors in numerous metabolic reactions that maintain body homeostasis and tissue functions. In addition to their metabolic functions, B- vitamins are also involved in DNA synthesis and repair, cellular differentiation, and redox balance. For example, cobalmin and folic acid are essential for one-carbon metabolism, directly influencing nucleic acid synthesis and epigenetic regulations. Pyridoxine plays an important role in amino acid metabolism and neurotransmitter synthesis, including dopamine, serotonin, and gamma aminobutyric acid, all of which are important for mental health and cognitive function. Riboflavin and niaiin are indespensable for cellular respiration and oxidative phosphorylation. Disruption of these pathways due to deficiency can result in serious neurological, hematological, and neuropsychiatric disorders in the susceptible population. Emerging therapeutics, including high-dose pharmacologic approaches, bioactive vitamin forms, and nanotechnology-based carriers (including nanoparticles, liposomes, and encapsulation techniques), are being developed to address deficiency through targeted interventions and to optimize the therapeutic potential in metabolic and chronic disease management. These innovative strategies improve abosprtion, minimize potential side effects, and reduce dosing frequency, thereby expanding their basic role beyond basic supplementation to therapeutic applications.